Annual FCF
-$76.32 M
-$13.00 M-20.54%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual free cash flow is -$76.32 million, with the most recent change of -$13.00 million (-20.54%) on December 31, 2023.
- During the last 3 years, OCUL annual FCF has fallen by -$21.93 million (-40.31%).
- OCUL annual FCF is now -496.82% below its all-time high of -$12.79 million, reached on December 31, 2012.
Performance
OCUL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$36.65 M
-$11.10 M-43.47%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly free cash flow is -$36.65 million, with the most recent change of -$11.10 million (-43.47%) on September 30, 2024.
- Over the past year, OCUL quarterly FCF has dropped by -$28.66 million (-358.62%).
- OCUL quarterly FCF is now -1138.53% below its all-time high of -$2.96 million, reached on September 30, 2013.
Performance
OCUL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$119.25 M
-$28.66 M-31.63%
September 30, 2024
Summary
- As of February 7, 2025, OCUL TTM free cash flow is -$119.25 million, with the most recent change of -$28.66 million (-31.63%) on September 30, 2024.
- Over the past year, OCUL TTM FCF has dropped by -$46.73 million (-64.44%).
- OCUL TTM FCF is now -3409.33% below its all-time high of -$3.40 million, reached on March 31, 2013.
Performance
OCUL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
OCUL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.5% | -358.6% | -64.4% |
| 3 y3 years | -40.3% | -176.4% | -107.5% |
| 5 y5 years | -49.3% | -83.6% | -49.4% |
OCUL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.5% | at low | -358.6% | at low | -101.1% | at low |
| 5 y | 5-year | -40.3% | +4.4% | -463.9% | at low | -125.8% | at low |
| alltime | all time | -496.8% | +4.4% | -1138.5% | at low | -3409.3% | at low |
Ocular Therapeutix Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$36.65 M(+43.5%) | -$119.25 M(+31.6%) |
| Jun 2024 | - | -$25.54 M(-25.2%) | -$90.59 M(+4.0%) |
| Mar 2024 | - | -$34.14 M(+49.0%) | -$87.11 M(+14.1%) |
| Dec 2023 | -$76.32 M(+20.5%) | -$22.91 M(+186.7%) | -$76.32 M(+5.2%) |
| Sep 2023 | - | -$7.99 M(-63.8%) | -$72.52 M(-7.6%) |
| Jun 2023 | - | -$22.07 M(-5.5%) | -$78.49 M(+15.8%) |
| Mar 2023 | - | -$23.35 M(+22.2%) | -$67.79 M(+7.1%) |
| Dec 2022 | -$63.32 M(-5.1%) | -$19.11 M(+36.8%) | -$63.32 M(+5.5%) |
| Sep 2022 | - | -$13.96 M(+22.8%) | -$59.99 M(+1.2%) |
| Jun 2022 | - | -$11.37 M(-39.8%) | -$59.29 M(-12.9%) |
| Mar 2022 | - | -$18.88 M(+19.6%) | -$68.10 M(+2.0%) |
| Dec 2021 | -$66.74 M(+22.7%) | -$15.78 M(+19.1%) | -$66.74 M(+16.2%) |
| Sep 2021 | - | -$13.26 M(-34.3%) | -$57.46 M(-1.1%) |
| Jun 2021 | - | -$20.18 M(+15.2%) | -$58.07 M(+10.0%) |
| Mar 2021 | - | -$17.52 M(+169.5%) | -$52.81 M(-2.9%) |
| Dec 2020 | -$54.40 M(-31.8%) | -$6.50 M(-53.2%) | -$54.40 M(-20.0%) |
| Sep 2020 | - | -$13.87 M(-7.0%) | -$67.96 M(-8.2%) |
| Jun 2020 | - | -$14.92 M(-21.9%) | -$74.06 M(-6.0%) |
| Mar 2020 | - | -$19.10 M(-4.8%) | -$78.81 M(-1.3%) |
| Dec 2019 | -$79.82 M(+56.1%) | -$20.07 M(+0.5%) | -$79.82 M(+8.0%) |
| Sep 2019 | - | -$19.96 M(+1.5%) | -$73.88 M(+13.2%) |
| Jun 2019 | - | -$19.67 M(-2.2%) | -$65.26 M(+11.8%) |
| Mar 2019 | - | -$20.11 M(+42.4%) | -$58.37 M(+14.2%) |
| Dec 2018 | -$51.12 M | -$14.13 M(+24.5%) | -$51.12 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$11.35 M(-11.3%) | -$47.94 M(-9.6%) |
| Jun 2018 | - | -$12.79 M(-0.5%) | -$53.01 M(-4.2%) |
| Mar 2018 | - | -$12.85 M(+17.4%) | -$55.35 M(-5.8%) |
| Dec 2017 | -$58.73 M(+63.5%) | -$10.95 M(-33.3%) | -$58.73 M(+4.7%) |
| Sep 2017 | - | -$16.42 M(+8.5%) | -$56.07 M(+17.2%) |
| Jun 2017 | - | -$15.13 M(-6.8%) | -$47.85 M(+11.9%) |
| Mar 2017 | - | -$16.23 M(+95.7%) | -$42.77 M(+19.1%) |
| Dec 2016 | -$35.92 M(+1.1%) | -$8.29 M(+1.1%) | -$35.92 M(-2.2%) |
| Sep 2016 | - | -$8.20 M(-18.4%) | -$36.74 M(-4.1%) |
| Jun 2016 | - | -$10.04 M(+7.1%) | -$38.31 M(+1.7%) |
| Mar 2016 | - | -$9.38 M(+3.0%) | -$37.67 M(+6.1%) |
| Dec 2015 | -$35.52 M(+63.3%) | -$9.11 M(-6.8%) | -$35.52 M(+9.4%) |
| Sep 2015 | - | -$9.78 M(+4.0%) | -$32.48 M(+10.8%) |
| Jun 2015 | - | -$9.40 M(+30.0%) | -$29.31 M(+18.8%) |
| Mar 2015 | - | -$7.23 M(+19.2%) | -$24.67 M(+13.4%) |
| Dec 2014 | -$21.76 M(+66.9%) | -$6.07 M(-8.2%) | -$21.76 M(+12.4%) |
| Sep 2014 | - | -$6.61 M(+38.8%) | -$19.35 M(+23.2%) |
| Jun 2014 | - | -$4.76 M(+10.1%) | -$15.70 M(+12.5%) |
| Mar 2014 | - | -$4.32 M(+18.0%) | -$13.96 M(+7.1%) |
| Dec 2013 | -$13.03 M(+1.9%) | -$3.66 M(+23.8%) | -$13.03 M(+39.1%) |
| Sep 2013 | - | -$2.96 M(-1.8%) | -$9.37 M(+46.2%) |
| Jun 2013 | - | -$3.01 M(-11.4%) | -$6.41 M(+88.6%) |
| Mar 2013 | - | -$3.40 M | -$3.40 M |
| Dec 2012 | -$12.79 M | - | - |
FAQ
- What is Ocular Therapeutix annual free cash flow?
- What is the all time high annual FCF for Ocular Therapeutix?
- What is Ocular Therapeutix annual FCF year-on-year change?
- What is Ocular Therapeutix quarterly free cash flow?
- What is the all time high quarterly FCF for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly FCF year-on-year change?
- What is Ocular Therapeutix TTM free cash flow?
- What is the all time high TTM FCF for Ocular Therapeutix?
- What is Ocular Therapeutix TTM FCF year-on-year change?
What is Ocular Therapeutix annual free cash flow?
The current annual FCF of OCUL is -$76.32 M
What is the all time high annual FCF for Ocular Therapeutix?
Ocular Therapeutix all-time high annual free cash flow is -$12.79 M
What is Ocular Therapeutix annual FCF year-on-year change?
Over the past year, OCUL annual free cash flow has changed by -$13.00 M (-20.54%)
What is Ocular Therapeutix quarterly free cash flow?
The current quarterly FCF of OCUL is -$36.65 M
What is the all time high quarterly FCF for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly free cash flow is -$2.96 M
What is Ocular Therapeutix quarterly FCF year-on-year change?
Over the past year, OCUL quarterly free cash flow has changed by -$28.66 M (-358.62%)
What is Ocular Therapeutix TTM free cash flow?
The current TTM FCF of OCUL is -$119.25 M
What is the all time high TTM FCF for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM free cash flow is -$3.40 M
What is Ocular Therapeutix TTM FCF year-on-year change?
Over the past year, OCUL TTM free cash flow has changed by -$46.73 M (-64.44%)